Catalyst calendar
The repricing schedule is mostly public if you actually look at it.
AllI · Sterile fill-finish capacityII · Stoppers, syringes & drug-contact componentsIII · Pharmaceutical glass & vialsIV · Bioprocessing consumables & resinsV · API & small-molecule reshoringVI · CDMO capacity & the China exodusVII · Peptide & oligonucleotide manufacturingVIII · Sterile injectables & shortage economicsIX · Analytical instruments & QC releaseX · Private giants & exposure vehicles
July 2026
- 30mediumEarningsMTDMettler-Toledo Q2 2026 earningsTracks demand for the validated balances, titrators and process analytics that underpin GMP measurement at every release step.
August 2026
- 04mediumEarningsWATWaters Q2 2026 earnings — first full quarter as combined Waters/BD entityFirst print showing the enlarged QC-instrument franchise's recurring-revenue mix and BD integration progress, the key test of the reshaped largest pure-QC name.
- 06mediumEarningsCRLCharles River Q2 2026 earningsReads the Endosafe/Microbial Solutions endotoxin franchise against CDMO drag, the gauge of the sterility-release gate amid the USP <86> reagent transition.
- 26mediumEarningsAAgilent fiscal Q3 2026 earningsTests whether the pharma-led LC/LC-MS/GC instrument recovery (low-double-digit growth) sustains, the cleanest read on chromatography-release demand.